Abstract:Study question: What is the longitudinal association between gestational phthalate exposure and in vivo placental outcomes? Summary answer: Phthalates were adversely associated with placental microvasculature, stiffness, and presence of calcification, with different metabolites associated with different outcomes. What is known already: Phthalate exposure is ubiquitous and implicated as a contributor to adverse pregnancy outcomes, possibly through impacts on the placenta. Study design, size, duration: A total of 303 women were recruited in early pregnancy and prospectively followed for up to eight visits across gestation in the Human Placenta and Phthalates study. Participants/materials, setting, methods: At each visit, women provided urine samples and underwent placental ultrasounds. Urine was analyzed for 18 metabolites of phthalates and replacements. We took the geometric mean of repeated measurements to reflect pregnancy-averaged phthalate or replacement exposure for each participant (n = 303). Placental microvasculature, stiffness, and microcalcification presence were quantified from ultrasounds at each visit. Higher scores reflected worse placental function for all measures. Generalized linear mixed models were created to estimate the association between pregnancy-averaged exposure biomarker concentrations and repeated outcome measurements for microvasculature and stiffness. Gestational age at the time of calcification detection was modeled using Cox proportional hazards models. Main results and the role of chance: Monocarboxyisononyl phthalate and summed di(2-ethylhexyl) phthalate metabolites were associated with impaired microvasculature development, such that an interquartile range increase in concentration was associated with 0.11 standard deviation increase in the microvasculature ratio, indicating poorer vascularization (95% CI: 0.00, 0.22); 0.11 [95% CI: -0.01, 0.22], respectively. Monoethyl phthalate was associated with increased placental stiffness (0.09 [95% CI: -0.01, 0.19]) while summed di-iso-butyl phthalate metabolites and monobenzyl phthalate were associated with increased hazard of calcification detection (hazard ratios: 1.18 [95% CI: 0.98, 1.42]; 1.13 [95% CI: 0.96, 1.34]). Limitations, reasons for caution: Outcomes used in this study are novel and further investigation is needed to provide clinical context and relevance. Wider implications of the findings: We found evidence of associations between select phthalate biomarkers and various aspects of in vivo placental health, although we did not observe consistency across placental outcomes. These findings could illustrate heterogeneous effects of phthalate exposure on placental function. Study funding/competing interest(s): This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (ZIA ES103344), and NIEHS T32ES007018. The authors declare that they have no competing interests to disclose. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the CDC, the Public Health Service, or the US Department of Health and Human Services. Trial registration number: N/A.

Biomarkers of Phthalates and Inflammation: Findings from a Subgroup of Women's Health Initiative Participants.

Association Between Urinary Phthalate Biomarker Concentrations and Adiposity among Postmenopausal Women.

Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women

Phthalates and Phenols, Leukocyte Telomere Length, and Breast Cancer Risk and Mortality in the Long Island Breast Cancer Study Project.

Exposure to phthalates and their alternatives in relation to biomarkers of inflammation and oxidative stress in adults: evidence from NHANES 2017-2018

Phthalate exposure and markers of biological aging: The mediating role of inflammation and moderating role of dietary nutrient intake

Association of urinary phthalate metabolites with estrogen receptor related cancers in American adults: A Nationwide Study, NHANES 2003-2006

Longitudinal associations between urinary biomarkers of phthalates and replacements with novel in vivo measures of placental health

Association of urinary phthalate metabolites with estrogen receptor related cancers in American adults: A Nationwide Study 2003-2006

Impact of phthalate metabolites on vitamin D levels and subclinical inflammation: national health and nutrition examination survey, 2013–2018

Chronic inflammation as a potential mediator between phthalate exposure and depressive symptoms

The association of serum phthalate metabolites with biomarkers of ovarian reserve in women of childbearing age

Associations Between Phthalate Metabolites and Cytokines in the Follicular Fluid of Women Undergoing in Vitro Fertilization.

Gender associations between phthalate exposure and biomarkers of oxidative stress: A prospective cohort study

The Association of Bisphenol A and Phthalates with Risk of Breast Cancer: A Meta-Analysis

Predictors and Correlations of Phthalate Metabolite Concentrations in Urine and Seminal Plasma among Reproductive-Aged Men.

Phthalate exposure increases interferon-γ during pregnancy: The Atlanta African American Maternal-Child Cohort

Di-(2-ethylhexyl) phthalate exposure links to inflammation and low bone mass in premenopausal and postmenopausal females: Evidence from ovariectomized mice and humans

Changes in epidemiologic associations with different exposure metrics: a case study of phthalate exposure associations with body mass index and waist circumference

Associations between phenols, parabens, and phthalates and depressive symptoms: The role of inflammatory markers and bioinformatic insights

The Association of Co-Exposure to Polycyclic Aromatic Hydrocarbon and Phthalates with Blood Cell-Based Inflammatory Biomarkers in Children: A Panel Study.